OXIDATIVE MECHANISMS OF HEMOGLOBIN-BASED BLOOD SUBSTITUTES^*

REFERENCES

• Alayash A I. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?. Nat Biotechnol 1999; 17: 545–549
   PubMed Web of Science ®Google Scholar
• Lio J C, Hein T W, Vaughn M W, et al. Intravacular flow decreases erthyrocyte consumption of nitric oxide. Pro Natl Acad Sci USA 1999; 96: 8757–8761
   PubMed Web of Science ®Google Scholar
• Patel R P, Mcandrew J, Sellak H, White C R, Jo H, Freeman B A, Darley Usmar V M. Biological aspects of reactive nitrogen species. Biochem Biophys Acta 1999; 1411: 385–400
   PubMed Web of Science ®Google Scholar
• Sattler M, Winkler T, Verma S, Byrne C H, Shrikhande G, Salgia R, Griffin J D. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 1999; 93: 2928–2935
   PubMed Web of Science ®Google Scholar
• Guyton K Z, Liu Y, Gorospe M, Xu Q, Holbrook N J. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 1996; 271: 4138–4142
   PubMed Web of Science ®Google Scholar
• Moinova H R, Mulcahy R T. An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-I site. J Biol Chem 1998; 273: 14683–14639
   PubMed Web of Science ®Google Scholar
• Muller J M, Rupec R A, Baeuerle P A. Study of gene regulation by NFκB and AP-1 in response to reactive oxygen intermediates. Methods 1997; 11: 301–312
   PubMed Web of Science ®Google Scholar
• Salmon J A, Garland L G. Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents. Prog Drug Res 1991; 37: 9–90
   PubMedGoogle Scholar
• Ramasamy S, Parthasarathy S, Harrison D G. Regulation of endothelial nitric oxid synthase gene expression by oxidized linoleic acid. J Lipid Res 1998; 39: 268–276
   PubMed Web of Science ®Google Scholar
• Young-Mi G, Patel R P, Maland M C, Park H, Beckman J S, Darley-Usmar V M, Jo H. Evidence for peroxynitrite as a signaling molecule in flowdependent activation of cJun N-terminal kinase in endothelial cells. Am J Physiol 1999; 277: H1647–H1653
   PubMedGoogle Scholar
• Everse J. The structure of heme proteins compounds I and II: some misconceptions. Free Rad Biol Med 1998; 24: 1338–1346
   PubMed Web of Science ®Google Scholar
• McLeod L L, Alayash A I. Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxia-reoxygenation. Am J Physiol 1999; 277: H92–H99
   PubMed Web of Science ®Google Scholar
• Everse J, Hsia N. The toxicities of native and modified hemoglobins. Free Rad Biol Med 1997; 22: 1075–1099
   PubMed Web of Science ®Google Scholar
• Catalano C E, Choe Y S, Ortiz de Montellano P R. Reactions of the protein radical in peroxide-treated myoglobin. Formation of a heme-protein cross-link. J Biol Chem 1989; 264: 10534–10541
   PubMed Web of Science ®Google Scholar
• Cashon R E, Alayash A I. Reactions of human hemoglobin A0 and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate. Arch Biochem Biophys 1995; 316: 461–469
   PubMed Web of Science ®Google Scholar
• Svistunenko D A, Patel R P, Wilson M T. An EPR investigation of human methaemoglobin oxidation by hydrogen peroxide: methods to quantify all paramagnetic species observed in the reaction. Free Rad Res 1996; 24: 269–280
   PubMed Web of Science ®Google Scholar
• Alayash A I, Patel R P, Cashon R E. Redox reactions of hemoglobin and myoglobin: biological and toxicological implications. Antiox Redox Signal 2001; 3: 313–327
   PubMed Web of Science ®Google Scholar
• D'Agnillo F, Wood F, Porras C, Macdonald V W, Alayash A I. Effects of hypoxia and glutathione depletion on hemoglobin and myoglobin-medaiated oxidative stress toward endothelium. Biochim Biophys Acta 2000; 1495: 150–159
   PubMed Web of Science ®Google Scholar
• Moore K P, Holt S, Patel R P, Svistunenko D A, Zackert W, Goodier D, Reeder B J, Clozel M, Anand R, Cooper C E, Harvey S, Morrow J D, Wilson M T, Darley-Usmar V M, Roberts L J. A Causative role for myoglobin induced lipid peroxidation in the renal failure of rhabdomyolysis: effect of alkalinization. J Biol Chem 1998; 273: 31731–31737
   PubMed Web of Science ®Google Scholar
• Ziouzenkova O, Asatryan L, Akmal M, Tetta C, Wratten M L, Loseto-Wich G, Jurgens G, Heinecke J, Sevanian A. Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis. J Biol Chem 1999; 274: 18916–18924
   PubMed Web of Science ®Google Scholar
• Svistunenko D A, Patel R P, Voloshchenko S V, Wilson M T. The globinbased free radical of ferryl hemoglobin is detected in normal human blood. J Biol Chem 1997; 272: 7114–7121
   PubMed Web of Science ®Google Scholar
• Osawa Y, Krozekwa K. Oxidative modifications by low levels of HOOH can transform myoglobin to an oxidase. Pro Natl Acad Sci USA 1991; 88: 7081–7085
   PubMed Web of Science ®Google Scholar
• Osawa Y, Williams M S. Covalent crosslinking of the heme prosthetic group to myoglobin by H2O2: toxicological implications. Free Rad Biol Med 1996; 21: 35–41
   PubMed Web of Science ®Google Scholar
• Nagababu E, Rifkind J M. Reaction of hydrogen peroxide with ferrylhemoglobin:superoxide production and heme degradation. Biochemistry 2000; 39: 12503–12511
   PubMed Web of Science ®Google Scholar
• Nagababu E, Rifkind J M. Heme degradation during autoxidation of oxyglobin. Biochem Biophys Res comm 2000; 273: 839–845
   PubMed Web of Science ®Google Scholar
• D'Agnillo F, Alayash A I. Site-specific modifications and toxicity of blood substitutes. The case of disapirin cross-linked hemoglobin. Adv Drug Deliv Rev 2000; 40: 199–212
   PubMed Web of Science ®Google Scholar
• Saxena R, Wijnhoud A D, Carton H, Hacke W, Kaste M, Przybelski R J, Stern K N, Koudstal P J. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999; 30: 993–996
   PubMed Web of Science ®Google Scholar
• Sloan E R, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory M, Rodman G. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial. J Am Med Ass 1999; 282: 1857–1864
   PubMed Web of Science ®Google Scholar
• Goldman D W, Breyer R J, Yeh D, Brockner Ryan B A, Alayash A I. Acellular hemoglobin-mediated oxidative stress toward endothelium: a role for ferryl iron. Am J Physiol 1998; 275: H1046–H1053
   PubMed Web of Science ®Google Scholar
• Burhop K E, Estep T E. Hemoglobin-induced myocardial lesions (abstract). VIII international Symposium on Blood Substitutes (ISBS), San Diego, 2000, 21
   Google Scholar
• Faivre B, Menu P, Labrude P, Vingeron C. Hemoglobin autooxidation/oxidation mechanisms and methemoglobin prevention or reduction processes in the bloodstream. Literature review and outline of autooxidation reaction. Art Cells Blood Sub Immob Biotech 1998; 1: 17–26
   Google Scholar
• Giulivi C, Davies K JA. A novel antioxidant role for hemoglobin. The comproportionation of ferrylhemoglobin with oxyhemoglobin. J Biol Chem 1990; 265: 19453–19460
   PubMed Web of Science ®Google Scholar
• Alayash A I, Brockner Ryan B A, Eich R F, Olson J S, Cashon R E. Reactions of sperm whale myoglobin with hydrogen peroxide. Effects of distal pocket mutations on the formation and stability of the ferryl intermediate. J Biol Chem 1999; 274: 2029–2037
   PubMed Web of Science ®Google Scholar
• Doherty D H, Doyle M P, Curry S R, Vali R J, Fattor T J, Olson J S, Lemon D D. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 1998; 16: 672–676
   PubMed Web of Science ®Google Scholar
• Talarico T, Swank A, Privalle C. Autoxidation of pyridoxylated hemoglobin polyoxyetheylene conjugate. Biochem Biophys Res Comm 1998; 250: 354–358
   PubMed Web of Science ®Google Scholar
• Talarico T L, Guise K J, Stacey C J. Chemical characterization of pyridoxalated hemoglobin polyoxyethylene conjugate. Biochem Biophys Acta 3 2000; 1476: 53–65
   PubMed Web of Science ®Google Scholar
• D'Agnillo F, Chang T MS. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol 1998; 16: 667–672
   PubMed Web of Science ®Google Scholar
• Okayama N, Park J H, Coe L, Granger D N, Ma L I, Hisa C J., Alexander J S. Polynitroxyl αα-hemoglobin (PNH) inhibits peroxide and superoxidemediated neutrophil adherence to human endothelial cells. Free Rad Res 1999; 31: 53–58
   PubMed Web of Science ®Google Scholar
• Admanson J G, McIntosh G A, Stewart J B, Wong L T. Synthesis and in vitro antioxidant activity of a polymerized hemoglobin-trolox conjugate. VIII International Symposium on Blood Substitutes (ISBS), San Diego, 2000, 60
   Google Scholar
• Feola M, Simoni J, Angelillo R. Preclinical and clinical experience with a novel hemoglobin adenosine-glutathione based red cell substitute. VIII [chInternational Symposium on Blood Substitutes (ISBS), San Diego, 2000, 27
   Google Scholar